European stock markets advanced modestly on Wednesday, supported by stronger-than-expected results from Novo Nordisk and a recovery in technology shares, while investors assessed early results from the US midterm elections and awaited fresh eurozone inflation figures. The pan-European STOXX 600 index gained 0.3%, with Novo Nordisk (TG:NOV) climbing nearly 6% after the Danish pharmaceutical group reported third-quarter adjusted operating profit above market expectations and raised its full-year sales and profit forecasts. Major European equity benchmarks traded higher, although gains remained limited amid uncertainty surrounding US political developments and the outlook for monetary policy. Germany's DAX increased 0.
Publicznie pokazujemy glowna mysl. Utworz darmowe konto, aby czytac caly artykul, zapisac go, omowic i polaczyc z kontekstem rynkowym oraz OSINT.